Tate & Lyle | TATE - Sales Revenues

Stock Price
536.50
Daily Change
0.50 0.09%
Monthly
50.49%
Yearly
-10.51%
Q2 Forecast
526.46

Tate & Lyle reported GBP1.02B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Agrana Beteiligungs EUR 802.4M 8.98M Sep/2025
Anglo-eastern Plants USD 230.47M 24.92M Jun/2025
Associated British Foods GBP 9.46B 490M Mar/2026
Austevoll Seafood NOK 9.81B 400M Mar/2026
Beiersdorf EUR 2.48B 170M Mar/2026
British American Tobacco GBP 13.5B 1.43B Dec/2025
Danone EUR 6.71B 170M Dec/2025
Diageo GBP 5.59B 3.76B Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
Imperial Brands GBP 4.52B 13.05B Mar/2026
International Flavors Fragrances USD 2.74B 150M Mar/2026
Kerry EUR 3.88B 0 Dec/2024
L'Oréal EUR 21.58B 10.84B Dec/2025
Nestle CHF 45.26B 1.03B Dec/2025
Nomad Foods EUR 715M 58M Mar/2026
Ontex EUR 881.3M 1000K Dec/2025
Pernod Ricard EUR 1.94B 3.31B Mar/2026
Premier Foods GBP 673.4M 25.4M Mar/2026
Primary Health Properties ZAR 169.3M 79.6M Dec/2025
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
Tate & Lyle GBP 1.02B 0 Dec/2025
Unilever EUR 12.59B 2.11B Dec/2025